Skip to content

Costs of care for persons with opioid dependence in commercial integrated health systems

When used in general medical practices, buprenorphine is an effective treatment for opioid dependence, yet little is known about how use of buprenorphine affects the utilization and cost of health care in commercial health systems. The objective of this retrospective cohort study was to examine how buprenorphine affects patterns of medical care, addiction medicine services, and costs from the health system perspective. Individuals with two or more opioid-dependence diagnoses per year, in two large health systems (System A: n = 1836; System B: n = 4204) over the time span 2007-2008 were included. Propensity scores were used to help adjust for group differences. Patients receiving buprenorphine plus addiction counseling had significantly lower total health care costs than patients with little or no addiction treatment (mean health care costs with buprenorphine treatment?=?$13,578; vs. mean health care costs with no addiction treatment?=?$31,055; p?

Authors: Lynch FL; McCarty D; Mertens J; Perrin NA; Green CA; Parthasarathy S; Dickerson JF; Anderson BM; Pating D

Addict Sci Clin Pract. 2014;9:16. Epub 2014-08-14.

PubMed abstract

Explore all studies and publications

Back To Top